Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Regola

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Clinical and Experimental Rheumatology|April 14, 2018
Circulating follicular helper T cells (CD4+CXCR5+ICOS+) decrease in patients with rheumatoid arthritis treated with abataceptSilvia Piantoni, Francesca Regola, Mirko Scarsi, et al.
Autoimmunity Reviews|October 25, 2019
Can we use NOACS in APS?Hagit Peleg, Yaakov Naparstek, Francesca Regola, et al.
Frontiers in Medicine|November 19, 2021
Novel Targets for Drug Use in Eosinophilic Granulomatosis With PolyangiitisMartina Uzzo, Francesca Regola, Barbara Trezzi, et al.
Frontiers in Medicine|January 31, 2022
Novel Therapies in Takayasu ArteritisFrancesca Regola, Martina Uzzo, Paola Toniati, et al.
Rheumatology Advances in Practice|July 21, 2020
Long-term treatment with tocilizumab in giant cell arteritis: efficacy and safety in a monocentric cohort of patientsFrancesca Regola, Elisabetta Cerudelli, Giovanni Bosio, et al.
Rheumatology (Oxford, England)|August 10, 2022
Tapering belimumab in patients with systemic lupus erythematosus: a single-centre experienceMicaela Fredi, Tamara Vojinovic, Francesca Regola, et al.
Clinical and Experimental Rheumatology|December 2, 2025
Giant cell arteritis in clinical practice: beyond GiACTAFrancesca Regola, Jacopo Mora, Matteo Riva, et al.
Clinical and Experimental Rheumatology|January 27, 2022
CXCL-13 serum levels in patients with rheumatoid arthritis treated with abataceptStefania Masneri, Silvia Piantoni, Giorgio Galoppini, et al.
Reumatismo|August 18, 2025
The use of tumor necrosis factor inhibitors during high-risk pregnancies in antiphospholipid syndrome: a clinical report of a patient with concomitant Takayasu arteritis and case-based reviewLiala Moschetti, Francesca Crisafulli, Francesca Regola, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Incidence and prevalence of systemic sclerosis in Valcamonica, Italy, during an 18-year periodPaolo Airò, Francesca Regola, Maria-Grazia Lazzaroni, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Rheumatology|April 14, 2018
Circulating follicular helper T cells (CD4+CXCR5+ICOS+) decrease in patients with rheumatoid arthritis treated with abataceptSilvia Piantoni, Francesca Regola, Mirko Scarsi, et al.
Autoimmunity Reviews|October 25, 2019
Can we use NOACS in APS?Hagit Peleg, Yaakov Naparstek, Francesca Regola, et al.
Frontiers in Medicine|November 19, 2021
Novel Targets for Drug Use in Eosinophilic Granulomatosis With PolyangiitisMartina Uzzo, Francesca Regola, Barbara Trezzi, et al.
Frontiers in Medicine|January 31, 2022
Novel Therapies in Takayasu ArteritisFrancesca Regola, Martina Uzzo, Paola Toniati, et al.
Rheumatology Advances in Practice|July 21, 2020
Long-term treatment with tocilizumab in giant cell arteritis: efficacy and safety in a monocentric cohort of patientsFrancesca Regola, Elisabetta Cerudelli, Giovanni Bosio, et al.
Rheumatology (Oxford, England)|August 10, 2022
Tapering belimumab in patients with systemic lupus erythematosus: a single-centre experienceMicaela Fredi, Tamara Vojinovic, Francesca Regola, et al.
Clinical and Experimental Rheumatology|December 2, 2025
Giant cell arteritis in clinical practice: beyond GiACTAFrancesca Regola, Jacopo Mora, Matteo Riva, et al.
Clinical and Experimental Rheumatology|January 27, 2022
CXCL-13 serum levels in patients with rheumatoid arthritis treated with abataceptStefania Masneri, Silvia Piantoni, Giorgio Galoppini, et al.
Reumatismo|August 18, 2025
The use of tumor necrosis factor inhibitors during high-risk pregnancies in antiphospholipid syndrome: a clinical report of a patient with concomitant Takayasu arteritis and case-based reviewLiala Moschetti, Francesca Crisafulli, Francesca Regola, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Incidence and prevalence of systemic sclerosis in Valcamonica, Italy, during an 18-year periodPaolo Airò, Francesca Regola, Maria-Grazia Lazzaroni, et al.
Pageof 3